Triple

T19104424
Position Surface form Disambiguated ID Type / Status
Subject BfArM E467617 entity
Predicate officialName P66 FINISHED
Object Bundesinstitut für Arzneimittel und Medizinprodukte NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Bundesinstitut für Arzneimittel und Medizinprodukte | Statement: [BfArM, officialName, Bundesinstitut für Arzneimittel und Medizinprodukte]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Bundesinstitut für Arzneimittel und Medizinprodukte
Context triple: [BfArM, officialName, Bundesinstitut für Arzneimittel und Medizinprodukte]
  • A. Federal Institute for Drugs and Medical Devices chosen
    The Federal Institute for Drugs and Medical Devices is Germany’s central regulatory authority responsible for the authorization, safety monitoring, and risk assessment of pharmaceuticals and medical devices.
  • B. Paul Ehrlich Institute
    The Paul Ehrlich Institute is Germany’s federal agency and research institution responsible for the evaluation, authorization, and monitoring of vaccines and biomedicines.
  • C. Swissmedic
    Swissmedic is the Swiss agency responsible for the authorization and supervision of therapeutic products, including medicines and medical devices, in Switzerland.
  • D. European Union Drugs Agency
    The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
  • E. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8dd05ac4c8190b1967d8f97f3fb2f completed April 10, 2026, 11:20 a.m.
NER Named-entity recognition batch_69e5e3704c688190b84ef82da45d0862 completed April 20, 2026, 8:27 a.m.
Created at: April 10, 2026, 12:04 p.m.